# Femoral Nerve Block Versus Adductor Canal Nerve Block for Peri-Operative Analgesia Following Anterior Cruciate Ligament (ACL) Reconstruction: Evaluation of Post-operative Pain and Strength

> **NCT03033589** · NA · COMPLETED · sponsor: **Henry Ford Health System** · enrollment: 78 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Marcaine 0.25 % Injectable Solution
- **DRUG:** Marcaine 0.25 % Injectable Solution

## Key facts

- **NCT ID:** NCT03033589
- **Lead sponsor:** Henry Ford Health System
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05
- **Primary completion:** 2017-07-31
- **Final completion:** 2017-12-31
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2024-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03033589

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03033589, "Femoral Nerve Block Versus Adductor Canal Nerve Block for Peri-Operative Analgesia Following Anterior Cruciate Ligament (ACL) Reconstruction: Evaluation of Post-operative Pain and Strength". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03033589. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*